中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
13期
36-36,38
,共2页
高血压%糖尿病%临床治疗
高血壓%糖尿病%臨床治療
고혈압%당뇨병%림상치료
Hypertension%Diabetes mellitus%Clinical treatment
目的:探讨高血压合并糖尿病的临床治疗方法及效果。方法:2013年5月-2014年7月收治高血压合并糖尿病患者100例,随机将其分为对照组与观察组,各50例,对照组实施替米沙坦治疗,观察组实施替米沙坦联合氨氯地平治疗,对两组患者治疗效果进行对比。结果:治疗后,观察组收缩压与舒张压下降率明显优于对照组,P<0.05,具有统计学意义。且观察组治疗后的血糖下降幅度明显优于对照组,P<0.05,具有统计学意义,治疗前后两组患者尿素氮、肌酐变化不明显,P>0.05,不具有统计学意义。结论:替米沙坦联合氨氯地平都能够降低患者血压与血糖水平,提升患者治疗依从性,值得临床应用与推广。
目的:探討高血壓閤併糖尿病的臨床治療方法及效果。方法:2013年5月-2014年7月收治高血壓閤併糖尿病患者100例,隨機將其分為對照組與觀察組,各50例,對照組實施替米沙坦治療,觀察組實施替米沙坦聯閤氨氯地平治療,對兩組患者治療效果進行對比。結果:治療後,觀察組收縮壓與舒張壓下降率明顯優于對照組,P<0.05,具有統計學意義。且觀察組治療後的血糖下降幅度明顯優于對照組,P<0.05,具有統計學意義,治療前後兩組患者尿素氮、肌酐變化不明顯,P>0.05,不具有統計學意義。結論:替米沙坦聯閤氨氯地平都能夠降低患者血壓與血糖水平,提升患者治療依從性,值得臨床應用與推廣。
목적:탐토고혈압합병당뇨병적림상치료방법급효과。방법:2013년5월-2014년7월수치고혈압합병당뇨병환자100례,수궤장기분위대조조여관찰조,각50례,대조조실시체미사탄치료,관찰조실시체미사탄연합안록지평치료,대량조환자치료효과진행대비。결과:치료후,관찰조수축압여서장압하강솔명현우우대조조,P<0.05,구유통계학의의。차관찰조치료후적혈당하강폭도명현우우대조조,P<0.05,구유통계학의의,치료전후량조환자뇨소담、기항변화불명현,P>0.05,불구유통계학의의。결론:체미사탄연합안록지평도능구강저환자혈압여혈당수평,제승환자치료의종성,치득림상응용여추엄。
Objective:To investigate the clinical treatment and curative effect of hypertension complicated with diabetes mellitus. Methods:100 patients with hypertension complicated with diabetes were selected from May 2013 to July 2014.They were randomly divided into the control group and the observation group.The control group was given the telmisartan treatment,and the observe group was given the telmisartan and amlodipine treatment.We compared the treatment effect of the two groups patients.Results:After the treatment,the systolic and diastolic blood pressure decreased rate of the patients in the observation group were significantly better than that of the control group,P<0.05,with statistical significance.And the blood glucose decreased range of the patients in the observation group after treatment was better than that of the control group significantly,P<0.05,with statistical significance.The blood urea nitrogen and creatinine of the two groups patients did not change significantly before and after treatment,P<0.05,without statistically significant.Conclusion:Telmisartan combined with amlodipine can lower the blood pressure and blood glucose levels of patients,and improve the therapeutic compliance of patients,so it is worthy of clinical application and promotion.